HMD Holstov Metabolic Dynamics
← Back to Investigational Systems
ZEMFIT vial
C187H291N45O59

ZEMFIT

Semaglutide

ZEMFIT is presented within HMD as an investigational system for scientific reading and molecular characterization. This profile connects the molecule with related historical and technical documentation within the HMD series.

TypeGLP-1 receptor agonist
Chemical / scientific nameModified peptide; N6,26-[18-[[(1S)-1-carboxy-4-[[2-[2-[2-[2-[2-[2-(2-aminoethoxy)ethoxy]acetyl]amino]ethoxy]ethoxy]acetyl]amino]butyl]amino]-18-oxooctadecanoyl]-[Aib8, Arg34]-human glucagon-like peptide-1-(7-37).
Molecular formulaC187H291N45O59

Technical profile

This profile is part of a documentary library of investigational systems. It does not constitute a clinical indication, therapeutic recommendation, prescription, commercial availability, or instructions for use.

Related literature

HMD-HG-015 · Semaglutide: Long Duration, Clinical Potency and Metabolic ExpansionHMD-HG-014 · GLP-1 and ObesityHMD-HG-013 · Early GLP-1 Receptor AgonistsHMD-HG-012 · The Pharmacological Problem of Native GLP-1HMD-HG-011 · GLP-1 Beyond Glucose

Research dossier

HMD-ED-001 — ZEMFIT Evidence Dossier

Semaglutide · Full Technical Brief. Document viewer for client-facing technical consultation, integrated into the molecular profile of the investigational system.

Technical viewer
HMD-ED-001 — ZEMFIT Evidence Dossier
12 pages · HMD technical reading

Loading dossier...